Related references
Note: Only part of the references are listed.Sirolimus Use and Cancer Incidence Among US Kidney Transplant Recipients
E. L. Yanik et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2015)
Cyclosporine A Drives a Th17-and Th2-Mediated Posttransplant Obliterative Airway Disease
P. H. Lemaitre et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Double Deficiency for RORγt and T-bet Drives Th2-Mediated Allograft Rejection in Mice
Manije Sabet-Baktach et al.
JOURNAL OF IMMUNOLOGY (2013)
Adoptive Transfer of Tc1 or Tc17 Cells Elicits Antitumor Immunity against Established Melanoma through Distinct Mechanisms
Yu Yu et al.
JOURNAL OF IMMUNOLOGY (2013)
A Color-Coded Reporter Model to Study the Effect of Immunosuppressants on CD8+ T-Cell Memory in Antitumor and Alloimmune Responses
Jordi Rovira et al.
TRANSPLANTATION (2013)
No Acceleration of UV-Induced Skin Carcinogenesis from Evenly Spread Dietary Intake of Cyclosporine in Contrast to Oral Bolus Dosages
Pieter Voskamp et al.
TRANSPLANTATION (2013)
Rapamycin impairs UV induction of mutant-p53 overexpressing cell clusters without affecting tumor onset
P. Voskamp et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Sirolimus and Secondary Skin-Cancer Prevention in Kidney Transplantation
Sylvie Euvrard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
In vivo tumor suppression activity by T cell-specific T-bet restoration
Kihyun Lee et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Adoptive Transfer of Tumor-Specific Tc17 Effector T Cells Controls the Growth of B16 Melanoma in Mice
Maria de la Luz Garcia-Hernandez et al.
JOURNAL OF IMMUNOLOGY (2010)
mTOR regulates memory CD8 T-cell differentiation
Koichi Araki et al.
NATURE (2009)
Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells
Luca Gattinoni et al.
NATURE MEDICINE (2009)
The roles of CD8 central and effector memory T-cell subsets in allograft rejection
M. H. Oberbarnscheidt et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Cancer incidence before and after kidney transplantation
Claire M. Vajdic et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation
Josep M. Campistol et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies
HM Kauffman et al.
TRANSPLANTATION (2005)
Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells
CA Klebanoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
NFAT proteins: Key regulators of T-cell development and function
F Macian
NATURE REVIEWS IMMUNOLOGY (2005)
Dosing of rapamycin is critical to achieve an optimal antiangiogenic effect against cancer
M Guba et al.
TRANSPLANT INTERNATIONAL (2005)
Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation
M Guba et al.
TRANSPLANTATION (2004)
Antigen-driven effector CD8 T cell function regulated by T-bet
BM Sullivan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
T-bet is required for optimal production of IFN-γ and antigen-specific T cell activation by dendritic cells
G Lugo-Villarino et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor
M Guba et al.
NATURE MEDICINE (2002)
Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipients
M Herman et al.
JOURNAL OF LABORATORY AND CLINICAL MEDICINE (2001)
Share Paper
